Swedish Pharma Looks For More Substance In Innovation Procurement Plan
Executive Summary
The Swedish government's proposals to encourage domestic innovation by having government purchasers suggest earlier in companies' research what kinds of new services are needed is drawing support, albeit somewhat tentatively, from the nation's pharma industry.
You may also be interested in...
Sweden’s Reference Pricing Proposal: A Five-Year Doomsday Clock For Innovation?
Sweden may link its existing value-based pricing system with international reference pricing to cut drug expenditure, a move the pharmaceuticals industry says would devastate domestic R&D there.
Spanish Pharma Industry Appeals Local Drug Funding Decisions
Spain's drug industry appeals against a court ruling allowing local drug funding decisions.
EU Drug Pricing: The Only Way Is Down
Pricing pressure in Europe is hardly new, but it became a much bigger concern in 2010. The last 18 months have seen some of the most severe and certainly the most numerous, price cuts across the region. Although individual European countries represent only a small share of Big Pharma revenues, the EU as a whole is the world's second-largest market in sales terms, only slightly smaller than the U.S.